240 related articles for article (PubMed ID: 35077194)
21. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
[TBL] [Abstract][Full Text] [Related]
22. Lymphedema Incidence After Axillary Lymph Node Dissection: Quantifying the Impact of Radiation and the Lymphatic Microsurgical Preventive Healing Approach.
Johnson AR; Kimball S; Epstein S; Recht A; Lin SJ; Lee BT; James TA; Singhal D
Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S234-S241. PubMed ID: 30855393
[TBL] [Abstract][Full Text] [Related]
23. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up.
Ribeiro Pereira ACP; Koifman RJ; Bergmann A
Breast; 2017 Dec; 36():67-73. PubMed ID: 28992556
[TBL] [Abstract][Full Text] [Related]
25. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.
Paramanandam VS; Dylke E; Clark GM; Daptardar AA; Kulkarni AM; Nair NS; Badwe RA; Kilbreath SL
J Clin Oncol; 2022 Jun; 40(18):2004-2012. PubMed ID: 35108031
[TBL] [Abstract][Full Text] [Related]
27. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?
Specht MC; Miller CL; Russell TA; Horick N; Skolny MN; O'Toole JA; Jammallo LS; Niemierko A; Sadek BT; Shenouda MN; Finkelstein DM; Smith BL; Taghian AG
Breast Cancer Res Treat; 2013 Aug; 140(3):485-94. PubMed ID: 23912961
[TBL] [Abstract][Full Text] [Related]
28. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.
Armer JM; Ballman KV; McCall L; Armer NC; Sun Y; Udmuangpia T; Hunt KK; Mittendorf EA; Byrd DR; Julian TB; Boughey JC
Support Care Cancer; 2019 Feb; 27(2):495-503. PubMed ID: 29980907
[TBL] [Abstract][Full Text] [Related]
29. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
[No Abstract] [Full Text] [Related]
30. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
[TBL] [Abstract][Full Text] [Related]
31. Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.
Wang L; Chen H; Li Y; Wang H; Liu N; Yu M; Shang S
Support Care Cancer; 2023 Apr; 31(5):278. PubMed ID: 37074508
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.
Togawa K; Ma H; Sullivan-Halley J; Neuhouser ML; Imayama I; Baumgartner KB; Smith AW; Alfano CM; McTiernan A; Ballard-Barbash R; Bernstein L
Breast Cancer Res; 2014 Aug; 16(4):414. PubMed ID: 25145603
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
34. The Risk of Subclinical Breast Cancer-Related Lymphedema by the Extent of Axillary Surgery and Regional Node Irradiation: A Randomized Controlled Trial.
Boyages J; Vicini FA; Shah C; Koelmeyer LA; Nelms JA; Ridner SH
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):987-997. PubMed ID: 33127493
[TBL] [Abstract][Full Text] [Related]
35. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
36. A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
Yue T; Zhuang D; Zhou P; Zheng L; Fan Z; Zhu J; Hou L; Yu F; Dong X; Xiao L; He Q
Clin Breast Cancer; 2015 Aug; 15(4):301-6. PubMed ID: 25776198
[TBL] [Abstract][Full Text] [Related]
37. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
38. Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up.
Sagen A; Kåresen R; Risberg MA
Acta Oncol; 2009; 48(8):1102-10. PubMed ID: 19863217
[TBL] [Abstract][Full Text] [Related]
39. Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer.
Gennaro M; Listorti C; Mariani L; Maccauro M; Bianchi G; Capri G; Maugeri I; Lozza L; De Santis MC; Folli S
Eur J Surg Oncol; 2021 Jul; 47(7):1606-1610. PubMed ID: 33160781
[TBL] [Abstract][Full Text] [Related]
40. Axillary Treatment and Chronic Breast Cancer-Related Lymphedema: Implications for Prospective Surveillance and Intervention From a Randomized Controlled Trial.
Boyages J; Vicini FA; Manavi BA; Gaw RL; Koelmeyer LA; Ridner SH; Shah C
JCO Oncol Pract; 2023 Dec; 19(12):1116-1124. PubMed ID: 37816208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]